hydrogen carbonate has been researched along with Anti-MuSK Myasthenia Gravis in 6 studies
Bicarbonates: Inorganic salts that contain the -HCO3 radical. They are an important factor in determining the pH of the blood and the concentration of bicarbonate ions is regulated by the kidney. Levels in the blood are an index of the alkali reserve or buffering capacity.
hydrogencarbonate : The carbon oxoanion resulting from the removal of a proton from carbonic acid.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, E | 1 |
Derfler, K | 1 |
Joukhadar, C | 1 |
Druml, W | 1 |
Thomas, CE | 1 |
Mayer, SA | 1 |
Gungor, Y | 1 |
Swarup, R | 1 |
Webster, EA | 1 |
Chang, I | 1 |
Brannagan, TH | 1 |
Fink, ME | 1 |
Rowland, LP | 1 |
Marques, MB | 1 |
Huang, ST | 1 |
Faradji-Hazan, V | 1 |
Oster, JR | 2 |
Fedeman, DG | 1 |
Clerch, AR | 1 |
Perez, GO | 2 |
Wacks, I | 1 |
Kett, DH | 1 |
Patten, BM | 1 |
Oliver, KL | 1 |
Engel, WK | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Evaluation of Filters Useful Life, Metabolic Control, Electrolyte Profile and Acid-base Balance During Regional Anticoagulation With 4% Trisodium Citrate in Patients Undergoing CVVHDF: Effects of Increased Blood Flow[NCT05796661] | 27 participants (Anticipated) | Interventional | 2023-01-09 | Recruiting | |||
Calcium Mass Balance and Dialytic Efficiency of a New cITRate-containing and Acetate-free Dialysis flUidS: CITRUS Study[NCT02848937] | 62 participants (Anticipated) | Observational | 2013-03-31 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
6 other studies available for hydrogen carbonate and Anti-MuSK Myasthenia Gravis
Article | Year |
---|---|
Citrate kinetics in patients receiving long-term hemodialysis therapy.
Topics: Acid-Base Imbalance; Adult; Anticoagulants; Bicarbonates; Citrates; Female; Hemodialysis Solutions; | 2005 |
Citrate kinetics in patients receiving long-term hemodialysis therapy.
Topics: Acid-Base Imbalance; Adult; Anticoagulants; Bicarbonates; Citrates; Female; Hemodialysis Solutions; | 2005 |
Citrate kinetics in patients receiving long-term hemodialysis therapy.
Topics: Acid-Base Imbalance; Adult; Anticoagulants; Bicarbonates; Citrates; Female; Hemodialysis Solutions; | 2005 |
Citrate kinetics in patients receiving long-term hemodialysis therapy.
Topics: Acid-Base Imbalance; Adult; Anticoagulants; Bicarbonates; Citrates; Female; Hemodialysis Solutions; | 2005 |
Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation.
Topics: Adult; Aged; Aged, 80 and over; Aging; Bicarbonates; Female; Humans; Infections; Lung; Male; Middle | 1997 |
Patients with thrombotic thrombocytopenic purpura commonly develop metabolic alkalosis during therapeutic plasma exchange.
Topics: Adult; Aged; Alkalosis; Bicarbonates; Citric Acid; Female; Humans; Kidney Function Tests; Liver Func | 2001 |
Effect of pyridostigmine bromide on serum bromide concentration and the anion gap.
Topics: Acid-Base Equilibrium; Adult; Bicarbonates; Bromides; Chlorides; Electrodes; Humans; Middle Aged; My | 1991 |
Spurious hyperchloremia and hyperbicarbonatemia in a patient receiving pyridostigmine bromide therapy for myasthenia gravis.
Topics: Acid-Base Equilibrium; Bicarbonates; Chlorides; Female; Humans; Middle Aged; Myasthenia Gravis; Pyri | 1990 |
Effect of lactate infusions on patients with myasthenia gravis.
Topics: Bicarbonates; Chlorides; Humans; Infusions, Parenteral; Ischemia; Lactates; Magnesium; Muscle Contra | 1974 |